Abcellera Biologics Inc
NASDAQ:ABCL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
CA |
|
M
|
MarineMax Inc
F:MLW
|
US |
|
M
|
MKS Instruments Inc
SWB:MKT
|
US |
|
Allreal Holding AG
OTC:ALRHF
|
CH |
|
I
|
IONOS Group SE
XBER:IOS
|
DE |
|
Savannah Resources Plc
F:SAV
|
UK |
|
S
|
SiteOne Landscape Supply Inc
F:0S0
|
US |
|
E
|
Ebix Inc
XMUN:EWZ
|
US |
|
Creative Technology Ltd
SGX:C76
|
SG |
|
M
|
MTU Aero Engines AG
XMUN:MTX
|
DE |
|
Severn Trent PLC
F:SVT
|
UK |
|
G
|
Galderma Group AG
SIX:GALD
|
CH |
|
RENERGEN Ltd
F:996
|
ZA |
|
Endesa SA
F:ENAA
|
ES |
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
|
Esprinet SpA
MIL:PRT
|
IT |
|
A
|
Avance Gas Holding Ltd
XMUN:A07
|
BM |
|
Hydrogenpro ASA
F:R6Z
|
NO |
|
K
|
Kendrion NV
F:K3E
|
NL |
Shareholder Yield
Current shareholder yield for ABCL is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ABCL Price
Abcellera Biologics Inc
| Average Annual Return | -33.82% |
| Standard Deviation of Annual Returns | 14.81% |
| Max Drawdown | -91% |
| Market Capitalization | 1.9B USD |
| Shares Outstanding | 305 380 000 |
| Percentage of Shares Shorted | 19.06% |
